Cargando…
Network meta-analysis of adjuvant treatments for patients with hepatocellular carcinoma after curative resection
PURPOSE: The prevention of recurrence for patients with hepatocellular carcinoma after curative resection is still a great challenge in clinical practice. There are numerous studies that trying to search for favorable strategies to decrease the recurrence and prolong life span for these patients, wh...
Autores principales: | Ye, Yanyan, Wang, Ying, Xu, Haoqian, Yi, Fengming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510134/ https://www.ncbi.nlm.nih.gov/pubmed/37730533 http://dx.doi.org/10.1186/s12876-023-02955-5 |
Ejemplares similares
-
Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection
por: Kuang, Xuejun, et al.
Publicado: (2018) -
Shanghai Score: A Prognostic and Adjuvant Treatment-evaluating System Constructed for Chinese Patients with Hepatocellular Carcinoma after Curative Resection
por: Sun, Hui-Chuan, et al.
Publicado: (2017) -
Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection
por: Jing, Chu-Yu, et al.
Publicado: (2017) -
Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma
por: Kudo, Masatoshi
Publicado: (2023) -
Adjuvant therapies after curative treatments for hepatocellular carcinoma: Current status and prospects
por: Zhu, Xiao-Dong, et al.
Publicado: (2020)